Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy.
第一作者:
Yoshimasa,Kosaka
第一单位:
Department of Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, 252-0374, Japan.
作者:
主题词
成年人(Adult);老年人(Aged);蒽环类(Anthracyclines);止吐药(Antiemetics);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);地塞米松(Dexamethasone);女(雌)性(Female);人类(Humans);异喹啉类(Isoquinolines);日本(Japan);中年人(Middle Aged);吗啉类(Morpholines);恶心(Nausea);奎宁环类(Quinuclidines);呕吐(Vomiting)
DOI
10.1007/s00520-015-2905-4
PMID
26349772
发布时间
2018-12-02
- 浏览59

Supportive care in cancer
1405-11页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文